Authors: Imaan Z. Kherani, Julia Farah, Rajinder Nirwan, Natalia Figueiredo, Anna Ells, Michael Fielden, R. Geoff Williams, Amin Kherani, Olga Ziozina.Author Disclosure Block: I.Z. Kherani: None. J. Farah: None. R. Nirwan: None. N. Figueiredo: None. A. Ells: None. M. Fielden: None. R. Williams: Membership on advisory boards or speakers’ bureaus; Name of for-profit or not-for-profit organization(s); Bayer, Novartis, Roche. Funded grants or clinical ...

Authors: Imaan Z. Kherani1, Chad Andrews2, Jennifer Pereira3, Larissa Moniz4, Cynthia X. Qian5. 1Temerty Faculty of Medicine, University of Toronto, 2College of Optometrists of Ontario, 3JRL Research & Consulting Inc., 4Fighting Blindness Canada, 5Department of Ophthalmology, Universite de Montreal.Author Disclosure Block: I.Z. Kherani: None. C. Andrews: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Fighting Blin...

Authors: Imaan Z. Kherani, Daiana R. Pur ,  Nupura K. Bakshi   Author Disclosures:   I.Z. Kherani:  None.  D.R. Pur:  None.  N.K. Bakshi:   Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Bayer, Novartis, Biogen, Roche, Teva. Any direct financial payments including receipt of honorar...